Literature DB >> 6430303

Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy.

H G Nüsslein, H Jahn, G Lösch, I Guggenmoos-Holzmann, W Leibold, J R Kalden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6430303     DOI： 10.1002/art.1780270718

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.

Authors:  M Tishler; D Caspi; E Gazit; M Yaron
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

2.  Tolerability and efficacy of oral chrysotherapy in patients with Sjögren's syndrome secondary to rheumatoid arthritis (SS-RA).

Authors:  A Mathieu; R Pala; P Nurchis; L Contu
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

3.  HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P Perrier; C Raffoux; P Thomas; J N Tamisier; M Busson; A Gaucher; F Streiff
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

4.  HLA antigens and gold toxicity in American blacks with rheumatoid arthritis.

Authors:  G S Alarcón; B O Barger; R T Acton; W J Koopman
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

5.  Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis.

Authors:  M Hakala; A H van Assendelft; J Ilonen; S Jalava; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1986-03       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.